AbbVie

ABBV · NYSE · USD

$262.82+1.11%+$2.89

Close · October 2, 2026

At a glance

Revenue growth: +8.57%; 2025 vs 2024
Net income growth: −1.22%; 2025 vs 2024
Net margin: 6.9%; 2024: 7.6%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Annual
Item	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016
Total assets	133,960	135,161	134,711	138,805	146,529	150,565	89,115	59,352	70,786	66,099
Current assets	29,062	25,582	33,002	28,463	27,928	24,173	49,519	16,945	21,223	16,187
Cash and equivalents	5,229	5,524	12,814	9,201	9,746	8,449	39,924	7,289	9,303	5,100
Short-term investments	28.0	31.0	2.0	28.0	84.0	30.0	—	772	486	1,323
Receivables	12,589	10,919	11,155	11,254	9,977	8,822	5,428	5,384	7,188	5,105
Inventory	4,951	4,181	4,099	3,579	3,128	3,310	1,813	1,605	1,605	1,444
Net property, plant and equipment	6,365	5,857	5,733	5,672	5,872	6,143	3,306	2,883	2,803	2,604
Goodwill	35,640	34,956	32,293	32,156	32,379	33,124	15,604	15,663	15,785	15,416
Other intangible assets	52,641	60,068	55,610	67,439	75,951	82,876	18,649	21,233	27,559	28,897
Long-term investments	298	279	304	241	303	424	124	1,420	2,090	1,783
Current liabilities	43,289	38,749	37,841	29,538	35,194	28,661	15,585	17,239	16,641	9,781
Accounts payable	3,592	2,945	3,688	2,934	2,882	2,276	1,452	1,546	1,474	1,407
Long-term debt	58,919	60,548	52,460	59,493	64,179	77,553	63,029	35,002	30,953	36,440
Total debt	65,901	68,250	60,579	64,582	77,583	87,063	67,164	36,611	36,968	36,465
Total liabilities	137,188	131,797	124,314	121,518	131,093	137,468	97,287	67,798	65,689	61,463
Total equity (incl. minority)	-3,228	3,364	10,397	17,287	15,436	13,097	-8,172	-8,446	5,097	4,636
Retained earnings	-15,493	-7,900	-1,000	4,784	3,127	1,055	4,717	3,368	5,459	4,378
Minority interest	42.0	39.0	37.0	33.0	28.0	21.0	—	—	—	—